Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DELORAZEPAM Cause Contraindicated product administered? 6 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Contraindicated product administered have been filed in association with DELORAZEPAM. This represents 0.3% of all adverse event reports for DELORAZEPAM.

6
Reports of Contraindicated product administered with DELORAZEPAM
0.3%
of all DELORAZEPAM reports
0
Deaths
6
Hospitalizations

How Dangerous Is Contraindicated product administered From DELORAZEPAM?

Of the 6 reports, 6 (100.0%) required hospitalization, and 5 (83.3%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DELORAZEPAM. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does DELORAZEPAM Cause?

Drug abuse (834) Sopor (630) Intentional self-injury (422) Intentional overdose (200) Suicide attempt (174) Toxicity to various agents (171) Overdose (114) Intentional product misuse (99) Coma (98) Somnolence (96)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which DELORAZEPAM Alternatives Have Lower Contraindicated product administered Risk?

DELORAZEPAM vs DELTA.8-TETRAHYDROCANNABINOL\HERBALS DELORAZEPAM vs DEMCIZUMAB DELORAZEPAM vs DEMEROL DELORAZEPAM vs DENOSUMAB DELORAZEPAM vs DEOXYCHOLIC ACID

Related Pages

DELORAZEPAM Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered DELORAZEPAM Demographics